Skip to content

Septerna, Inc. SEPN Operating Income

Operating Income at other companies

Amgen logo
AmgenAMGN
$2.67B+126%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$53.42M-148%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-$24.22M+10.7%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-$92.5M-47.1%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
-$3.4M+99.3%
Precigen logo
PrecigenPGEN
-$5.99M+73.5%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.65B+319%
Enterprise value$1.6B+1,325%
P/S22.8×-379×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s operating income?
Septerna, Inc. (SEPN) reported operating income of -$13.3M in Q1 2026.
How has Septerna, Inc.'s operating income changed year-over-year?
Septerna, Inc.'s operating income increased by 48.7% year-over-year, from -$25.91M to -$13.3M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.